CHA Healthcare Singapore has entered into a share purchase agreement to invest S$50 million in Catalist-listed Singapore Medical Group (SMG), increasing its stake from 6.86 per cent to 24.13 per cent...

SINGAPORE Medical Group on Tuesday posted a net profit of S$2.94 million for the fourth quarter ended Dec 31, up 17.2 per cent from a year ago.

STARTUPS

A NEW telehealth startup has emerged with the backing of Singapore Medical Group (SMG), the Catalist-listed clinic operator. HiDoc, which is 80 per cent-owned by SMG, officially launched its...

SINGAPORE Medical Group's earnings surged in the third quarter, tracking a rise in revenue and helped by the group's share of results where joint ventures and associates had earlier...

SINGAPORE Medical Group (SMG) may implement a formal dividend policy in fiscal 2019 along with a share buy-back mandate as part of its plan to enhance shareholder value, the Catalist-listed clinic...

SINGAPORE Medical Group (SMG), a specialist practitioner focused on women's health and wellness, on Tuesday reported a net profit of S$3.42 million for its first quarter ended March 31, 2018,...

CATALIST-listed clinic operator Singapore Medical Group (SMG) said on Friday night that a suit had been brought against it on Oct 30 last year, relating to alleged trademark and copyright...

Singapore Medical Group > Buy

DBS Equity Research has issued a 'Buy' recommendation on Singapore Medical Group (SMG) with a target price of S$0.73 a share. ...

CATALIST-LISTED Singapore Medical Group (SMG) is acquiring an 85 per cent stake in Pheniks which operates local aesthetics clinic SW1, with plans to expand the brand across the region.